Emergent BioSolutions Inc. EBS

Updated: 9 Aug 2026

NYSE | Biotech | Pharmaceuticals and biodefense

No signal published yet

We already track Emergent BioSolutions and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Emergent BioSolutions free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Pharmaceuticals and biodefense
We're already tracking Emergent BioSolutions Inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, the company reported second-quarter revenue of $234.3 million and announced an organizational restructuring plan expected to generate $40 million in annualized cost savings. The cost-cutting initiative includes reducing 93 staff positions and closing two research laboratories.

What Firelda Watch includes for Emergent BioSolutions Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Emergent BioSolutions Inc. will be delivered in the same format.

Want to follow Emergent BioSolutions Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Emergent BioSolutions free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Emergent BioSolutions Inc. EBS
Emergent BioSolutions — follow and we'll monitor it
Follow Emergent BioSolutions free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.